Using AI to accelerate drug development

University of Waterloo researchers are using AI to accelerate the drug development process, helping scientists identify promising treatments faster and more efficiently. By leveraging advanced machine learning techniques, their approach can analyze vast amounts of biological and chemical data, reducing the time and cost typically required to bring new drugs to market. This work has the potential to transform how diseases are studied and treated, enabling quicker responses to emerging health challenges and improving outcomes for patients worldwide.

To read the full article, click here!